Transplantation, HomologousStem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem CellsTransplantation ChimeraGraft vs Leukemia EffectEmbryonic Stem CellsGraft vs Tumor EffectBone Marrow TransplantationVidarabineBusulfanPeripheral Blood Stem Cell TransplantationAdult Stem CellsRemission InductionMyeloablative AgonistsRecurrenceTissue DonorsTreatment OutcomePluripotent Stem CellsCytomegalovirus InfectionsHistocompatibility TestingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteLymphocyte TransfusionLeukemiaTransplantation, AutologousMinor Histocompatibility AntigensLymphocyte DepletionStem Cell NicheVirus ActivationSiblingsGraft SurvivalImmunosuppressive AgentsNeural Stem CellsInduced Pluripotent Stem CellsNeoplasm, ResidualCell DifferentiationMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaSalvage TherapyAntilymphocyte SerumHematopoietic Stem Cell MobilizationT-LymphocytesRetrospective StudiesMultiple MyelomaCytomegalovirusMultipotent Stem CellsWhole-Body IrradiationSurvival AnalysisCombined Modality TherapyMesenchymal Stem Cell TransplantationTrans Fatty AcidsMesenchymal Stromal CellsChimerismSurvival RateHistocompatibilityPrimary MyelofibrosisDisease-Free SurvivalRoseolovirus InfectionsStem Cell FactorTime FactorsLeukemia, Myeloid, Accelerated PhaseAnemia, AplasticAcute DiseaseCells, CulturedBenzamidesHepatic Veno-Occlusive DiseaseCord Blood Stem Cell TransplantationFusion Proteins, bcr-ablAntibodies, NeoplasmBone Marrow CellsAntigens, CD34Receptors, Purinergic P2X5PyrimidinesFlow CytometryCyclophosphamideCell ProliferationCell LineageLeukemia, MyeloidAntineoplastic Combined Chemotherapy ProtocolsLeukocyte TransfusionAntineoplastic AgentsImmunotherapy, AdoptivePiperazinesMice, Inbred C57BLGanciclovirImmunocompromised HostHematologic DiseasesPrognosisHLA AntigensTransplantation ImmunologyCell SeparationNuclear FamilyStem Cell ResearchMelphalanImmunosuppression